Page 2 - Immunization Practices News Today

This is the first time an mRNA jab has been approved for a disease other than COVID-19.

The KP.2 subvariant is now dominant in the U.S., FDA staff says in a briefing document

State comptroller investigated how the Israel Ministry of Health handled adverse event reports.

Bringing Taiwan to the World and the World to Taiwan

Don’t let COVID-19 be an obstacle to your health: your immune system needs exercise just like your body.

This cross-sectional study uses data from retail pharmacies to examine shingles vaccine uptake among Medicare Part D beneficiaries following an IRA policy

The county's public health office said wastewater samples indicate that local transmission is on the rise.

Updates follow federal recommendations to protect children and communities against vaccine-preventable diseases

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1...

Generated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® $25.6 million for EMPAVELI® Anticipates CHMP opinion for pegcetacoplan...